MRI Used to Visualize Microscopic Flow
|
By LabMedica International staff writers Posted on 04 Nov 2010 |
Of the tools used to examine material structures at the atomic and molecular scales, there is none better than nuclear magnetic resonance (NMR) spectroscopy and its daughter technology magnetic resonance imaging (MRI). Now, the latest development from the research group of one of the world's foremost authorities on NMR/MRI technology has the potential for NMR/MRI results that are better and faster than ever before--a million times faster.
Through a combination of remote instrumentation, JPEG-style image compression algorithms and other major refinements, chemist Dr. Alexander Pines and members of his research group have been able to use NMR/MRI to image materials flowing through microfluidic "lab-on-a-chip” devices and zoom in on microscopic objects of specific interest with unprecedented spatial and time resolutions. Dr. Pines holds joint appointments with the Lawrence Berkeley National Laboratory (Berkeley Lab; Berkeley, CA, USA) and the University of California (UC) at Berkeley (USA).
"What excites me most about this new methodology is the possibility of a mobile, chip-based NMR/MRI platform for microfluidic analysis. Who knows? This might turn out to be useful for chemistry and biomedicine,” remarked Dr. Pines, an internationally recognized leader in the development of NMR technology, who is a faculty senior scientist in Berkeley Lab's materials sciences division and a professor of chemistry at UC Berkeley.
This latest study, which focused on MRI, has been reported October 7, 2010, in the journal Science. Coauthoring the paper with Dr. Pines included Dr. Vikram Bajaj, who is still a member of the Pines' group. According to Dr. Bajaj, first author on the Science article, "We have been able to conclusively demonstrate the ability to record microscopic images of flowing macroscopic objects without loss of sensitivity, something that is impossible in conventional MRI. We were also able to illustrate how MRI can be used to measure flow dynamics quantitatively and with high spatial resolution in real microfluidic devices. The spatial resolution we achieved is sufficient to capture the results of hundreds or thousands of parallel assays on a microfluidic device. Furthermore, we recorded these images approximately one million times faster than could be done with a conventional MRI experiment. This means that experiments which would have taken years to complete are now practical considerations.”
NMR/MRI signals are made possible by a feature found in the atomic nuclei called "spin,” which makes the nuclei act as if they were bar magnets. Obtaining an NMR/MRI signal depends upon an excess of nuclei in a sample with spins pointing either "north” or "south.” In the signal-encoding phase of NMR/MRI, the nuclei are exposed to a magnetic field and subjected to radiofrequency pulses so that they absorb and re-emit energy at signature frequencies. In the signal-detection phase of NMR/MRI, the frequencies of the encoded signals are either directly measured to obtain a spectrum (NMR), or used to obtain a second, spatially encoded signal that can then be translated into images (MRI).
MRI has become a fundamental part of modern medicine, providing physicians with a diagnostic tool that is noninvasive, quick, and involves no ionizing radiation that can damage cells and tissue. However, traditional MRI requires huge doughnut-shaped machines that fill an entire room and are extremely expensive to buy and operate. Recently, Dr. Pines and his group have taken great steps towards making NMR/MRI technology compact, portable, and comparatively inexpensive. It began with the decoupling of the NMR/MRI signal encoding and signal detection processes, which made remote NMR/MRI possible and widened the technology to lab-on-a-chip microfluidic assays of gases and liquids. With these new developments, Dr. Pines and his group have laid the foundation for new NMR/MRI applications in portable chemical and biomedical analysis.
"Our goal is to develop NMR/MRI appliances for portable chemical analysis of complex mixtures, including blood, urine, and saliva,” Dr. Bajaj stated. "Ultimately, we would like to make it possible to use NMR/MRI in point of care clinical analysis.”
In their new Science study, Drs. Pines and Bajaj and their coauthors described how they were able to apply MRI technology to research involving microscopic flow through microfluidic or biologic channels, or through porous materials. The key was the incorporation of several new elements into their remote NMR/MRI configuration. This included the fabrication of microsolenoid MRI probes with demountable microfluidic device holders, the design of remote MRI sequences for spatial encoding in the presence of motion, as well as for velocimetric measurements, and the use of JPEG-style compressive sampling algorithms for accelerated image encoding.
"The combination of remote NMR/MRI methods with these new elements spectroscopically mimics the implantation of a coil around a microscopic feature of interest and allows us to zoom in on the microscopic details of microfluidic flow dynamics in three spatial dimensions,” concluded Dr. Bajaj. "The mechanism of remote detection is analogous to that of a magnetic recording tape on which complex data are first encoded and later read out by a single stationary detector as the tape advances.”
Related Links:
University of California at Berkeley
Through a combination of remote instrumentation, JPEG-style image compression algorithms and other major refinements, chemist Dr. Alexander Pines and members of his research group have been able to use NMR/MRI to image materials flowing through microfluidic "lab-on-a-chip” devices and zoom in on microscopic objects of specific interest with unprecedented spatial and time resolutions. Dr. Pines holds joint appointments with the Lawrence Berkeley National Laboratory (Berkeley Lab; Berkeley, CA, USA) and the University of California (UC) at Berkeley (USA).
"What excites me most about this new methodology is the possibility of a mobile, chip-based NMR/MRI platform for microfluidic analysis. Who knows? This might turn out to be useful for chemistry and biomedicine,” remarked Dr. Pines, an internationally recognized leader in the development of NMR technology, who is a faculty senior scientist in Berkeley Lab's materials sciences division and a professor of chemistry at UC Berkeley.
This latest study, which focused on MRI, has been reported October 7, 2010, in the journal Science. Coauthoring the paper with Dr. Pines included Dr. Vikram Bajaj, who is still a member of the Pines' group. According to Dr. Bajaj, first author on the Science article, "We have been able to conclusively demonstrate the ability to record microscopic images of flowing macroscopic objects without loss of sensitivity, something that is impossible in conventional MRI. We were also able to illustrate how MRI can be used to measure flow dynamics quantitatively and with high spatial resolution in real microfluidic devices. The spatial resolution we achieved is sufficient to capture the results of hundreds or thousands of parallel assays on a microfluidic device. Furthermore, we recorded these images approximately one million times faster than could be done with a conventional MRI experiment. This means that experiments which would have taken years to complete are now practical considerations.”
NMR/MRI signals are made possible by a feature found in the atomic nuclei called "spin,” which makes the nuclei act as if they were bar magnets. Obtaining an NMR/MRI signal depends upon an excess of nuclei in a sample with spins pointing either "north” or "south.” In the signal-encoding phase of NMR/MRI, the nuclei are exposed to a magnetic field and subjected to radiofrequency pulses so that they absorb and re-emit energy at signature frequencies. In the signal-detection phase of NMR/MRI, the frequencies of the encoded signals are either directly measured to obtain a spectrum (NMR), or used to obtain a second, spatially encoded signal that can then be translated into images (MRI).
MRI has become a fundamental part of modern medicine, providing physicians with a diagnostic tool that is noninvasive, quick, and involves no ionizing radiation that can damage cells and tissue. However, traditional MRI requires huge doughnut-shaped machines that fill an entire room and are extremely expensive to buy and operate. Recently, Dr. Pines and his group have taken great steps towards making NMR/MRI technology compact, portable, and comparatively inexpensive. It began with the decoupling of the NMR/MRI signal encoding and signal detection processes, which made remote NMR/MRI possible and widened the technology to lab-on-a-chip microfluidic assays of gases and liquids. With these new developments, Dr. Pines and his group have laid the foundation for new NMR/MRI applications in portable chemical and biomedical analysis.
"Our goal is to develop NMR/MRI appliances for portable chemical analysis of complex mixtures, including blood, urine, and saliva,” Dr. Bajaj stated. "Ultimately, we would like to make it possible to use NMR/MRI in point of care clinical analysis.”
In their new Science study, Drs. Pines and Bajaj and their coauthors described how they were able to apply MRI technology to research involving microscopic flow through microfluidic or biologic channels, or through porous materials. The key was the incorporation of several new elements into their remote NMR/MRI configuration. This included the fabrication of microsolenoid MRI probes with demountable microfluidic device holders, the design of remote MRI sequences for spatial encoding in the presence of motion, as well as for velocimetric measurements, and the use of JPEG-style compressive sampling algorithms for accelerated image encoding.
"The combination of remote NMR/MRI methods with these new elements spectroscopically mimics the implantation of a coil around a microscopic feature of interest and allows us to zoom in on the microscopic details of microfluidic flow dynamics in three spatial dimensions,” concluded Dr. Bajaj. "The mechanism of remote detection is analogous to that of a magnetic recording tape on which complex data are first encoded and later read out by a single stationary detector as the tape advances.”
Related Links:
University of California at Berkeley
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







